Legal & General Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-177,719
| Closed | -$15.1M | – | 3519 |
|
|
2020
Q3 | $15.1M | Buy |
177,719
+3,406
| +2% | +$290K | 0.01% | 865 |
|
|
2020
Q2 | $6.18M | Buy |
174,313
+58,190
| +50% | +$2.06M | ﹤0.01% | 1208 |
|
|
2020
Q1 | $1.57M | Buy |
116,123
+4,288
| +4% | +$57.8K | ﹤0.01% | 1680 |
|
|
2019
Q4 | $2.37M | Buy |
111,835
+16,481
| +17% | +$349K | ﹤0.01% | 1720 |
|
|
2019
Q3 | $1.26M | Buy |
95,354
+16,724
| +21% | +$222K | ﹤0.01% | 1904 |
|
|
2019
Q2 | $1.09M | Buy |
78,630
+6,935
| +10% | +$96.1K | ﹤0.01% | 1931 |
|
|
2019
Q1 | $1.38M | Buy |
71,695
+13,395
| +23% | +$257K | ﹤0.01% | 1854 |
|
|
2018
Q4 | $832K | Buy |
58,300
+9,593
| +20% | +$137K | ﹤0.01% | 1964 |
|
|
2018
Q3 | $1.01M | Buy |
48,707
+1,082
| +2% | +$22.5K | ﹤0.01% | 1951 |
|
|
2018
Q2 | $1.13M | Sell |
47,625
-4,733
| -9% | -$112K | ﹤0.01% | 1888 |
|
|
2018
Q1 | $765K | Buy |
52,358
+26,270
| +101% | +$384K | ﹤0.01% | 1995 |
|
|
2017
Q4 | $423K | Sell |
26,088
-903
| -3% | -$14.6K | ﹤0.01% | 2127 |
|
|
2017
Q3 | $376K | Buy |
26,991
+1,514
| +6% | +$21.1K | ﹤0.01% | 2151 |
|
|
2017
Q2 | $222K | Buy |
25,477
+1,747
| +7% | +$15.2K | ﹤0.01% | 2271 |
|
|
2017
Q1 | $154K | Sell |
23,730
-1,583
| -6% | -$10.3K | ﹤0.01% | 2354 |
|
|
2016
Q4 | $93K | Buy |
25,313
+11,216
| +80% | +$41.2K | ﹤0.01% | 2612 |
|
|
2016
Q3 | $45K | Sell |
14,097
-2,123
| -13% | -$6.78K | ﹤0.01% | 2576 |
|
|
2016
Q2 | $37K | Hold |
16,220
| – | – | ﹤0.01% | 2631 |
|
|
2016
Q1 | $41K | Hold |
16,220
| – | – | ﹤0.01% | 2497 |
|
|
2015
Q4 | $49K | Hold |
16,220
| – | – | ﹤0.01% | 2473 |
|
|
2015
Q3 | $27K | Hold |
16,220
| – | – | ﹤0.01% | 2672 |
|
|
2015
Q2 | $64K | Hold |
16,220
| – | – | ﹤0.01% | 2423 |
|
|
2015
Q1 | $62K | Hold |
16,220
| – | – | ﹤0.01% | 2381 |
|
|
2014
Q4 | $78K | Hold |
16,220
| – | – | ﹤0.01% | 2157 |
|
|
2014
Q3 | $60K | Buy |
+16,220
| New | +$60K | ﹤0.01% | 2284 |
|